Status:

ENROLLING_BY_INVITATION

Bryophyllum Pinnatum Tea as a Novel Treatment for Recurrent Kidney Stone Formers

Lead Sponsor:

Indra Gupta

Conditions:

Kidney Calculi

Calcium Oxalate Kidney Stones

Eligibility:

All Genders

18-70 years

Phase:

EARLY_PHASE1

Brief Summary

The aim of this randomized placebo-controlled double-blind crossover clinical trial is to test the ability of a traditional tea made from the leaf of the Bryophyllum pinnatum (B. pinnatum) plant in de...

Detailed Description

Background and Rationale: Kidney stones are hard deposits that consist of calcium complexed with phosphate or oxalate, thus, high urinary calcium content is a major risk factor. The precipitation of ...

Eligibility Criteria

Inclusion

  • 18-70 years of age at time of study enrollment
  • 1 calcium-based stone event within a 3-year interval and/or hypercalciuria on a 24h urine collection (\>5 mmol/day)
  • They had an ultrasound or CT imaging within the previous 6 months which showed no evidence of current obstructive kidney stone
  • Adhering to the stone prevention diet (high water/low salt/low protein intake) for at least one month prior to enrollment in study but not taking any stone-preventing medications
  • Agrees to maintain current lifestyle habits and avoid taking new supplements during the study period

Exclusion

  • Patients with secondary causes for calcium stone formation (primary hyperparathyroidism, inflammatory bowel disease, hyperuricosuria, and cancer)
  • Patients who are pregnant or nursing or who are trying to become pregnant
  • Currently consuming B. pinnatum or any natural health product containing polyphenols
  • A known intolerance or allergy to the plant B. pinnatum
  • Currently taking stone-preventing medication
  • Gluten intolerance or allergy

Key Trial Info

Start Date :

November 7 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT06987084

Start Date

November 7 2024

End Date

December 31 2025

Last Update

May 23 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

McGill University Health Centre (Glen Site)

Montreal, Quebec, Canada, H4A 3J1